15-48495575-G-T
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000138.5(FBN1):c.2433C>A(p.Cys811*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. C811C) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_000138.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- familial thoracic aortic aneurysm and aortic dissectionInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Marfan syndromeInheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P, PanelApp Australia, Orphanet, Ambry Genetics
- Acromicric dysplasiaInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
- progeroid and marfanoid aspect-lipodystrophy syndromeInheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
- stiff skin syndromeInheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Weill-Marchesani syndrome 2, dominantInheritance: AD Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- geleophysic dysplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated ectopia lentisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal Marfan syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Weill-Marchesani syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- ectopia lentis 1, isolated, autosomal dominantInheritance: AD Classification: LIMITED Submitted by: G2P
- Shprintzen-Goldberg syndromeInheritance: AD, Unknown Classification: LIMITED, NO_KNOWN Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FBN1 | ENST00000316623.10 | c.2433C>A | p.Cys811* | stop_gained | Exon 21 of 66 | 1 | NM_000138.5 | ENSP00000325527.5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:2
The C811X pathogenic variant in the FBN1 gene has been previously reported in association with Marfan syndrome (Hung et al., 2009; Wypasek et al., 2013). Hung et al. (2009) identified C811X in a Taiwanese patient or family fulfilling Ghent criteria for Marfan syndrome, although specific clinical information was not provided. Subsequently, Wypasek et al. (2013) reported C811X in a Polish female proband with Marfan syndrome. While the proband had several maternal relatives with clinical histories suspicious for Marfan syndrome, genetic testing of informative relatives was not performed at the time of publication (Wypasek et al., 2013). The C811X variant is classified in ClinVar as pathogenic or likely pathogenic by two other clinical laboratories (SCV000052362.1, SCV000319270.1; Landrum et al., 2016). C811X is predicted to cause loss of normal protein function either by protein truncation or nonsense-mediated mRNA decay. Multiple other nonsense variants in the FBN1 gene have been reported in Human Gene Mutation Database in association with FBN1-related disorders, including Marfan syndrome (Stenson et al., 2014). Furthermore, the C811X variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). -
- -
Marfan syndrome Pathogenic:1
- -
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
The p.C811* pathogenic mutation (also known as c.2433C>A), located in coding exon 20 of the FBN1 gene, results from a C to A substitution at nucleotide position 2433. This changes the amino acid from a cysteine to a stop codon within coding exon 20. In a study of Taiwanese patients with Marfan syndrome, this mutation was detected in an individual fulfilling Ghent criteria with cardiovascular, ocular, and dural manifestations; this variant was also reported in one individual from a Polish Marfan syndrome cohort (Hung CC et al. Ann. Hum. Genet., 2009 Nov;73:559-67; Wypasek E et al. Pol. Arch. Med. Wewn., 2013;123:646-7). In addition to the clinical data presented in the literature, this alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at